|
MechanismAdenosine receptor antagonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date07 Mar 1951 |
100 Clinical Results associated with Suzhou Maidisen Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Suzhou Maidisen Pharmaceutical Co., Ltd.
100 Deals associated with Suzhou Maidisen Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Suzhou Maidisen Pharmaceutical Co., Ltd.